Informations techniques
Exploitant
OMNIVISION GmbH
Présentation
BRIMONIDINE OMNIVISION 2 mg/ml, collyre en solution en récipients unidoses - 60 récipients unidoses de 0,35 ml (CIP : 34009 301 500 3 0)
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
nD94ptUTFrdwh0y0